Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX1 | Q9Y5S8 | 10/20 | 0.57 |
| ▸ | MAPT | P10636 | 7/20 | 0.57 |
| ▸ | GAA | P10253 | 6/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | SNCA | P37840 | 3/20 | 0.57 |
| ▸ | BCHE | P06276 | 2/20 | 0.57 |
| ▸ | ACHE | P22303 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.57 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.57 |
| ▸ | MAOA | P21397 | 1/20 | 0.57 |
| ▸ | CNR1 | P21554 | 1/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | HTR2C | P28335 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16613229 | 0.90 | NOX1 (0.50) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL10456330 | 0.86 | NOX1 (0.53) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL10530491 | 0.80 | NOX1 (0.67) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL30274184 | 0.80 | NOX1 (0.67) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL29962430 | 0.79 | NOX1 (0.59) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL9935786 | 0.79 | NOX1 (0.53) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL10419393 | 0.78 | NOX1 (0.57) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL194062 | 0.77 | NOX1 (0.61) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL31331504 | 0.77 | NOX1 (0.61) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL88106 | 0.76 | NOX1 (0.59) | NOX1MAPTGAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116284077-A | Boron-containing azophenothiazine color-changing material and application thereof in fluoride ion detection | 青海大学 | 2023-06-23 | — | — | CN | claimed |
| CN-116284077-B | Boron-containing azophenothiazine color-changing material and application thereof in fluoride ion detection | 青海大学 | 2026-03-24 | — | — | CN | disclosed |
| CN-116284077-A | Boron-containing azophenothiazine color-changing material and application thereof in fluoride ion detection | 青海大学 | 2023-06-23 | — | — | CN | disclosed |
| CN-116284077-A | Boron-containing azophenothiazine color-changing material and application thereof in fluoride ion detection | 青海大学 | 2023-06-23 | — | — | CN | disclosed |
| US-20100285087-A1 | SINGLE PHENOTHIAZINE ENANTIOMERS AS AGENTS FOR THE PREVENTION OF BONE LOSS | THE UNIVERSITY OF TEXAS (US) | 2010-11-11 | — | — | US | disclosed |
| US-5539107-A | REACTION OF CHLOROPYRIDINE AND CHLOROQUINOLINES WITH MERCAPTOANILINES OR BIS/O-AMINOPHENYL DISULFIDE | ASTA MEDICA AKTIENGESELLSCHAFT (DE) | 1996-07-23 | — | — | US | disclosed |
| US-4985559-A | Used for Contact and Intraocular Lenses; Phenothiazine (Meth)acrylates or (Meth)acrylamide derivatives | UNIVERSITY OF FLORIDA (US) | 1991-01-15 | — | — | US | disclosed |
| EP-0344244-A1 | UV ABSORBING VINYL MONOMERS AND POLYMERS AND OCULAR IMPLANTS PREPARED THEREFROM | THE UNIVERSITY OF FLORIDA (US) | 1989-12-06 | — | — | EP | disclosed |
| WO-1989003386-A1 | UV ABSORBING VINYL MONOMERS AND POLYMERS AND OCULAR IMPLANTS PREPARED THEREFROM | UNIVERSITY OF FLORIDA (US) | 1989-04-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100285087-A1 | SINGLE PHENOTHIAZINE ENANTIOMERS AS AGENTS FOR THE PREVENTION OF BONE LOSS | ALPL, ENY2, BMP2 | NOX1 4014/4885MAPT 3791/4885GAA 450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.